M05BB05 • alendronic acid + calcium + cholecalciferol • Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates, combinations
The combination of alendronic acid, calcium, and colecalciferol (vitamin D3) is used for the prevention and treatment of osteoporosis, particularly in postmenopausal women or individuals at high risk of bone fractures. This combination helps maintain bone health by reducing bone loss and increasing bone density.
- Alendronic acid is a bisphosphonate that inhibits bone resorption by reducing the activity of osteoclasts (cells that break down bone).
- Calcium is essential for the formation and maintenance of healthy bones, contributing to their mineralization.
- Colecalciferol (vitamin D3) enhances calcium absorption in the intestines and helps the body use it effectively.
This combination should be taken as directed by a doctor, usually in the morning on an empty stomach, to maximize the absorption of alendronic acid. It is important to remain upright for at least 30 minutes after taking it to prevent esophageal irritation. Long-term use should be monitored to avoid side effects such as hypercalcemia or gastrointestinal issues.
Substance: alendronic acid + calcium + cholecalciferol
Date of last drug list: 02-10-2013
Commercial code: W59683001
Concentration: 70mg / 1000mg / 880UI
Pharmaceutical form: film-coated tablets+effervescent tablets
Quantity: 1
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.